ENGITIX
Engitix is using its proprietary human organ decellularisation technology to develop tissue engineered products for application in regenerative medicine and drug-target research. Engitixโ core expertise is treatment and research of liver disease using its proprietary technologies for human extra-cellular matrix (ECM) scaffolds and 3D spheroids for bioartificial liver devices. The scaffold technology is applicable to other organs and disease aetiologies including pancreatic and intestine scaffold products.
ENGITIX
Social Links:
Industry:
Biotechnology Health Care Life Science
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.engitix.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0)204 530 7654
Email Addresses:
[email protected]
Total Funding:
60.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins
Similar Organizations
Current Advisors List
Current Employees Featured
Founder
Investors List
DOMPE
DOMPE investment in Series A - Engitix
Netherton Investments
Netherton Investments investment in Series A - Engitix
Official Site Inspections
http://www.engitix.com Semrush global rank: 3.59 M Semrush visits lastest month: 4.02 K
- Host name: 153.131.153.160.host.secureserver.net
- IP address: 160.153.131.153
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260